August 29, 2025

Remote screening for asymptomatic atrial fibrillation

/ Research update / /

JAMA Peer-Reviewed Publication JAMA Network About The Study: In this remote randomized clinical trial, mail-based atrial fibrillation (AF) screening with an electrocardiogram patch in older patients at moderate to high risk of stroke led to a modest long-term increase in AF diagnosis at 2.5 years. Corresponding Authors: To contact the corresponding authors, email Rohan Wijesurendra, DPhil, rohan.wijesurendra@ndph.ox.ac.uk and Barbara […]

Remote screening for asymptomatic atrial fibrillation Read More »

SEOULTECH researchers develop revolutionary 3D-printed smart materials create high-performance pressure sensors for wearables

/ Research update / /

Breakthrough metamaterial technology leads to next-generation wearable devices and health monitoring Peer-Reviewed Publication Seoul National University of Science & Technology FacebookXLinkedInWeChatBlueskyMessageWhatsAppEmail image: The proposed metamaterial-based tactile sensing technology is expected to revolutionize the design of wearable devices and health monitoring. view moreCredit: Dr. Soonjae Pyo from SeoulTech Tactile sensors are widely used in robotics, prosthetics,

SEOULTECH researchers develop revolutionary 3D-printed smart materials create high-performance pressure sensors for wearables Read More »

Physiology-guided complete revascularization in older patients with myocardial infarction

/ Research update / /

JAMA Cardiology Peer-Reviewed Publication JAMA Network About The Study: In patients 75 years or older with myocardial infarction and multivessel disease, the benefit of physiology-guided complete revascularization over culprit-lesion–only treatment was sustained at 3 years. Corresponding Author: To contact the corresponding author, Simone Biscaglia, MD, email bscsmn@unife.it. To access the embargoed study: Visit our For The Media website at

Physiology-guided complete revascularization in older patients with myocardial infarction Read More »

Report indicates some mental conditions raise heart disease risk, mortality rate by nearly 100%

/ Research update / /

by Emory University edited by Sadie Harley, reviewed by Andrew Zinin   Credit: CC0 Public Domain Every 34 seconds, someone in the United States dies from heart disease. As nearly half of the country suffers from some form of cardiovascular disease (CVD), another one in four adults experience a mental health disorder in their lifetime, signaling an inevitable overlap. Now,

Report indicates some mental conditions raise heart disease risk, mortality rate by nearly 100% Read More »

Repurposed multiple sclerosis drug could help bones heal faster

/ Research update / /

by Steve Benowitz, University of Arizona edited by Sadie Harley, reviewed by Andrew Zinin Credit: Pixabay/CC0 Public Domain Researchers at the University of Arizona College of Medicine—Tucson found evidence that a drug that improves the ability to walk in people with multiple sclerosis can also make bone fractures heal faster. The findings help further the understanding of specific

Repurposed multiple sclerosis drug could help bones heal faster Read More »

More nonsmokers are getting lung cancer: Oncologist explains why

/ Clinical Practice / /

by Morayo Ogunbayo edited by Sadie Harley, reviewed by Andrew Zinin Credit: Unsplash/CC0 Public Domain The demographics of lung cancer change every day. The disease, which directly affects the respiratory system, has long been associated with smokers—but that is rapidly changing. “Before it was rare, but now it’s more and more,” Dr. Ioana Bonta told The Atlanta

More nonsmokers are getting lung cancer: Oncologist explains why Read More »

FDA orders earlier MRI scans for Leqembi

/ News update / /

The Food and Drug Administration is tightening safety rules for Eisai and Biogen’s Alzheimer’s drug Leqembi, calling for an earlier MRI scan between the second and third infusions of the biologic. This comes after regulators identified six deaths linked to brain swelling, or amyloid-related imaging abnormalities with edema. Up until now, scans were only required before the fifth,

FDA orders earlier MRI scans for Leqembi Read More »

Reimagining vision: Redefining eye treatment for a healthier future

/ Research update / /

by Wits University edited by Sadie Harley, reviewed by Robert Egan Kruti Naik, a Ph.D. candidate in ocular drug delivery at the Wits Advanced Drug Delivery Platform (WADDP) at Wits University, could change the way eye infections and conditions are treated. Eye drops are the go-to treatment, but Naik is determined to find efficient and cheaper ways to

Reimagining vision: Redefining eye treatment for a healthier future Read More »

Why the magic mushroom anti-aging claims are overblown

/ Clinical Practice / / ,

by Mikael Palner, The Conversation edited by Sadie Harley, reviewed by Andrew Zinin   Credit: Unsplash/CC0 Public Domain How can we live longer? The eternal question, and one that scientists have long been trying to answer. We know that diet, exercise, and genes play a big role in the aging process and how long each of us might be alive for. We also know

Why the magic mushroom anti-aging claims are overblown Read More »

I’m autistic and don’t speak: Here’s what I want you to know

/ Clinical Practice / /

by Timothy HoYuan Chan, The Conversation edited by Sadie Harley, reviewed by Andrew Zinin Credit: Unsplash/CC0 Public Domain My travels with autism started long before my diagnosis, at the age of three years and three months. My family noticed autistic features from around 15 months of age. I never looked at people and did not respond when called. I lined

I’m autistic and don’t speak: Here’s what I want you to know Read More »

Need Help?

We are here to help.

Vitae, vulputate lorem id egestas neque egestas habitant sit ante nec.

Contact Us Now
InnovateMed Medical Group

✆ Phone (appointments): 714-639-4013
Email: care@imedmg.com
Address: 615 E Chapman Ave, Suite #300, Orange, CA 92866

Review Rating
Instagram Facebook Linkedin X-twitter
Scroll to Top